Itonis Distribution of Its EMESYL™ Nausea Relief Seeking Marketing Evaluation to Air Infomercial With "As Seen On TV"

Posted 09:00:00 02/10/2015 by Admin

LAGUNA HILLS, CA--(Marketwired - Feb 10, 2015) - Itonis (OTC PINK: ITNS) is pleased that its distributor (Hensley Brothers Distribution, LLC) has shipped Itonis' EMESYL™ Nausea Relief product to As Seen On TV Productions for efficacy and marketing evaluation. (
If accepted, EMESYL™ Nausea Relief will be incorporated into a full Direct Response campaign that includes television and a Direct Response specific website. The television distribution will utilize only ABC, NBC, CBS, FOX and major cable networks to bring attention to EMESYL™ Nausea Relief. The 60-second commercial will air a minimum of 150 times in precise demographic locations.
According to Steven Hensley, Vice President of Hensley Brothers Distribution, "We expect feedback from the company very shortly, and Infomercials featuring EMESYL™ Nausea Relief could air as early as May 2015."
"In addition to rolling out EMESYL™ Nausea Relief on and at Lodi, California retail outlets, the potential television exposure on 'As Seen On TV' would present great opportunities to market EMESYL™ for retail sales," said Mark Cheung, CEO of Itonis.
About Itonis Pharmaceuticals
Itonis Pharmaceuticals, a division of Itonis, Inc., is headed by Charles Hensley, Ph.D., and its mission is to create and market over-the-counter and prescription homeopathic products that better people's lives. Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of the company that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.
About Itonis, Inc.
Located in Laguna Hills, California, and founded in 2005, Itonis Inc. has focused on transitioning itself in the past year from acquiring high growth, market niche entrepreneurial companies, to a market leader focused on the distribution of innovative products to the medical and pharmaceutical industry. Please visit
Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.
Itonis, Inc.
Email Contact


Stock Quote - ITNS

ITNS Last:  $N/A Change:  --

Investor Relations

Itonis Holdings Company is a trade name of Itonis Inc. (OTC:ITNS), a publicly traded company.

Contact our office at (949) 200-8887 or email us at for more information.